Functional enrichment analysis of selected clusters by approach
The excel file of Table 15 can be downloaded by clicking here
Approach | Tissue | Cluster passing quality criteria | Class | Cluster size | Term | Term description | Nominal p-value | Hub genes mapping the term | Adjusted p-value |
---|---|---|---|---|---|---|---|---|---|
I | VAT | dark-grey | Risk | 103 | KEGG | ECM-receptor interaction | 0.0086 | ITGA1, CD47 | 0.0086 |
I | VAT | dark-grey | Risk | 103 | KEGG | D-Glutamine and D-glutamate metabolism | 0.0217 | GLS2 | 0.0217 |
I | VAT | grey60 | Protection | 173 | KEGG | Non-alcoholic fatty liver disease (NAFLD) | 0.0014 | LEP, NDUFA2, NDUFB8, NDUFB9, NDUFS3 | 0.0014 |
I | VAT | grey60 | Protection | 173 | KEGG | Insulin signaling pathway | 0.0071 | RHOQ, RPS6, SHC1 | 0.0071 |
I | VAT | light-green | Risk | 158 | GO | positive regulation of MHC class I biosynthetic process | 0.0005 | CIITA, NLRC5 | 0.0005 |
I | VAT | light-green | Risk | 158 | KEGG | Primary immunodeficiency | 0.0200 | TAP2, CIITA | 0.0200 |
I | VAT | light-yellow | Risk | 149 | KEGG | Intestinal immune network for IgA production | 0.0033 | HLA-DPB1 | 0.0033 |
I | VAT | light-yellow | Risk | 149 | KEGG | Inflammatory bowel disease (IBD) | 0.0100 | HLA-DPB1 | 0.0100 |
I | SMT | black | Risk | 229 | KEGG | Arginine and proline metabolism | 0.0019 | ALDH4A1 | 0.0019 |
I | SMT | black | Risk | 229 | KEGG | RNA polymerase | 0.0040 | POLR1C, POLR2J, POLR2J2, POLR2J3 | 0.0040 |
I | SMT | black | Risk | 229 | GO | Proline metabolic process | 0.0054 | ALDH4A1 | 0.0054 |
I | SMT | dark-green | Protection | 464 | KEGG | Regulation of lipolysis in adipocytes | 0.0135 | ABHD5, FABP4, AKT3 | 0.0135 |
I | SMT | dark-green | Protection | 464 | KEGG | TNF signaling pathway | 0.0193 | RIPK1, CFLAR, MAP2K3, ATF2, CCL5 | 0.0193 |
I | SMT | dark-red | Protection | 139 | GO | Negative regulation of B cell differentiation | 0.0004 | HMGB3 | 0.0004 |
I | SMT | dark-red | Protection | 139 | GO | Positive regulation of macrophage differentiation | 0.0043 | PRKCA | 0.0043 |
I | SMT | green-yellow | Protection | 192 | GO | Heterochromatin assembly | 0.0002 | BAHD1 | 0.0002 |
I | SMT | green-yellow | Protection | 192 | GO | Positive regulation of double-strand break repair via homologous recombination | 0.0034 | ACTR2 | 0.0034 |
I | SMT | green-yellow | Protection | 192 | GO | Regulation of megakaryocyte differentiation | 0.0047 | CNOT4, ASH2L | 0.0047 |
I | SMT | green-yellow | Protection | 192 | KEGG | Hippo signaling pathway - multiple species | 0.0397 | LIMD1 | 0.0397 |
I | SMT | light-green | Protection | 1680 | GO | Synaptic vesicle to endosome fusion | 0.0005 | VAMP4, EEA1 | 0.0005 |
I | SMT | light-green | Protection | 1680 | KEGG | AGE-RAGE signaling pathway in diabetic complications | 0.0214 | TGFB1, FN1, PLCD1, PRKCB, SERPINE1 | 0.0214 |
I | SMT | purple | Protection | 209 | KEGG | Nicotinate and nicotinamide metabolism | 0.0055 | NAMPT | 0.0055 |
I | SMT | purple | Protection | 209 | KEGG | Biosynthesis of unsaturated fatty acids | 0.0312 | HACD2 | 0.0312 |
II | VAT | brown | Protection | 627 | GO | Regulation of cell communication by electrical coupling involved in cardiac conduction | 0.0001 | CALM1, CALM2, CALM3, CAMK2D | 0.0001 |
II | VAT | brown | Protection | 627 | KEGG | Complement and coagulation cascades | 0.0020 | PLG, PLAT, CFB, C3, C1R, CD59, CLU, VTN | 0.0020 |
II | VAT | brown | Protection | 627 | KEGG | Glioma | 0.0038 | EGFR, CALM1, CALM2, CALM3, CAMK2D, MDM2, CCND1 | 0.0038 |
II | VAT | green | Protection | 447 | KEGG | Glycine, serine and threonine metabolism | 0.0051 | GCSH, GAMT, SARDH | 0.0051 |
II | VAT | green | Protection | 447 | KEGG | RIG-I-like receptor signaling pathway | 0.0316 | DDX58, IFNA7, ATG5 | 0.0316 |
II | VAT | pink | Risk | 335 | KEGG | cAMP signaling pathway | 0.0057 | GCG, ADRB1, HTR4, SST, PTGER3, CAMK2B, GRIN2C, ATP1A3, ATP2B3, PDE4A | 0.0057 |
II | VAT | pink | Risk | 335 | KEGG | Cholesterol metabolism | 0.0483 | ABCA1, APOE | 0.0483 |
II | VAT | purple | Risk | 240 | GO | Branched-chain amino acid biosynthetic process | 0.0002 | BCAT1, BCAT2 | 0.0002 |
II | VAT | purple | Risk | 240 | KEGG | Valine. leucine and isoleucine biosynthesis | 0.0008 | BCAT1, BCAT2 | 0.0008 |
II | VAT | purple | Risk | 240 | KEGG | Linoleic acid metabolism | 0.0328 | PLA2G12A, CYP2J2 | 0.0328 |
II | VAT | yellow | Risk | 620 | KEGG | p53 signaling pathway | 0.0007 | CHEK1, CDK2, BAX, BBC3, TP53AIP1, APAF1, CASP9, SERPINE1, SESN1, COP1 | 0.0007 |
II | VAT | yellow | Risk | 620 | KEGG | Inflammatory bowel disease (IBD) | 0.0450 | HLA-DMA, HLA-DRB1, HLA-DRB4, HLA-DRB5, SMAD2, GATA3 | 0.0450 |
II | SMT | blue | Risk | 947 | KEGG | cGMP-PKG signaling pathway | 0.0060 | EDNRA, ADRA2C, NFATC3, NPR2, KCNMA1, ATP1A1, ATP2A3, CNGB1, ADCY1, ADCY6, PDE2A, PDE3B, ADRB1, KCNJ8 | 0.0060 |
II | SMT | blue | Risk | 947 | KEGG | Regulation of lipolysis in adipocytes | 0.0147 | ADRB1, ADCY1, ADCY6, FABP4, PDE3B | 0.0147 |
II | SMT | cyan | Risk | 159 | GO | Regulation of cytokine secretion involved in immune response | 0.0002 | ATG5 | 0.0002 |
II | SMT | cyan | Risk | 159 | GO | Transposition. RNA-mediated | 0.0007 | L1TD1 | 0.0007 |
II | SMT | grey-60 | Protection | 81 | KEGG | TGF-beta signaling pathway | 0.0598 | INHBB, E2F5 | 0.0598 |
II | SMT | grey-60 | Protection | 81 | KEGG | Fatty acid elongation | 0.1023 | HACD2 | 0.1023 |
II | SMT | magenta | Risk | 288 | GO | Positive regulation of ryanodine-sensitive calcium-release channel activity | 0.0002 | CALM3, CALM1, CALM2 | 0.0002 |
II | SMT | magenta | Risk | 288 | KEGG | Ras signaling pathway | 0.0094 | FGFR1, FGFR2, PDGFRA, GNG4, CALM2, CALM3, CALM1, RASA4, RASA4B | 0.0094 |
II | SMT | magenta | Risk | 288 | KEGG | Complement and coagulation cascades | 0.0227 | F5, PROCR, C3, C1R | 0.0227 |
II | SMT | purple | Protection | 286 | KEGG | Thermogenesis | 0.0150 | ATP5F1E, DPF3, MAP2K3, MAPK14, PRKAA2, UQCRQ, UQCR11, SMARCC1 | 0.0150 |
II | SMT | purple | Protection | 287 | KEGG | FoxO signaling pathway | 0.0182 | TGFBR2, PRKAA2, MAPK14, TNFSF10, GABARAPL1, SOD2 | 0.0182 |
II | SMT | purple | Protection | 286 | KEGG | Fluid shear stress and atherosclerosis | 0.0193 | TXN2, THBD, PRKAA2, MAP2K5, DUSP1, MAPK14 | 0.0193 |
II | SMT | salmon | Risk | 181 | KEGG | Pathways in cancer | 0.0266 | LEF1, COL4A4, BIRC7, MDM2, PRKCB, IL15, CAMK2A, NQO1, KLK3 | 0.0266 |
II | SMT | salmon | Risk | 181 | KEGG | Ubiquitin mediated proteolysis | 0.0387 | MDM2, BIRC7, FZR1 | 0.0387 |
II | SMT | tan | Risk | 234 | KEGG | MAPK signaling pathway | 0.0021 | VEGFC, TEK, RRAS2, RPS6KA2, GADD45B, TAB2, MAP3K20, MAP2K3, HSPA8, MECOM | 0.0021 |
II | SMT | tan | Risk | 234 | KEGG | Endocrine and other factor-regulated calcium reabsorption | 0.0359 | TRPV5, ATP1A2, GNAQ | 0.0359 |
III | Inter-tissue | green-yellow | Risk | 139 | GO | cGMP biosynthetic process | 0.0023 | NPR2, GUCY1B1 | 0.0023 |
III | Inter-tissue | green-yellow | Risk | 139 | GO | cGMP-mediated signaling | 0.0026 | CD36, NPR2, GUCY1B1 | 0.0026 |
III | Inter-tissue | green-yellow | Risk | 139 | KEGG | Insulin resistance | 0.0123 | PIK3R2, SOCS3, CD36, MLX | 0.0123 |
III | Inter-tissue | green-yellow | Risk | 139 | KEGG | Adipocytokine signaling pathway | 0.0196 | SOCS3, CD36, RXRA | 0.0196 |
III | Inter-tissue | green-yellow | Risk | 139 | KEGG | Non-alcoholic fatty liver disease (NAFLD) | 0.0206 | PIK3R2, RXRA, MLX | 0.0206 |
III | Inter-tissue | green-yellow | Risk | 139 | KEGG | Vascular smooth muscle contraction | 0.0221 | KCNMA1, CALCRL, NPR2, GUCY1B1 | 0.0221 |
III | Inter-tissue | magenta | Risk | 140 | GO | Regulation of extrinsic apoptotic signaling pathway via death domain receptors | 0.0010 | CFLAR | 0.0010 |
III | Inter-tissue | magenta | Risk | 140 | KEGG | Valine. leucine and isoleucine biosynthesis | 0.0282 | BCAT2 | 0.0282 |
III | Inter-tissue | magenta | Risk | 140 | KEGG | Vasopressin-regulated water reabsorption | 0.0458 | CREB3L3 | 0.0458 |
III | Inter-tissue | skyblue-3 | Protection | 91 | GO | Positive regulation of SREBP signaling pathway | 0.0045 | ZBTB7B | 0.0045 |
III | Inter-tissue | skyblue-3 | Protection | 91 | GO | Lipid droplet formation | 0.0055 | SQLE | 0.0055 |
III | Inter-tissue | skyblue-3 | Protection | 91 | KEGG | Hedgehog signaling pathway | 0.0281 | ARRB1, SPOPL | 0.0281 |
III | Inter-tissue | skyblue-3 | Protection | 91 | KEGG | MAPK signaling pathway | 0.0480 | PPP3CC, ARRB1, PTPN5 | 0.0480 |
III | Inter-tissue | tan | Protection | 139 | GO | Positive regulation of monocyte chemotaxis | 0.0048 | HMGB1, CCL5 | 0.0048 |
III | Inter-tissue | tan | Protection | 139 | KEGG | p53 signaling pathway | 0.0161 | CCND2, PIDD1 | 0.0161 |
III | Inter-tissue | tan | Protection | 139 | KEGG | Arrhythmogenic right ventricular cardiomyopathy (ARVC) | 0.0285 | ITGB8, ATP2A2 | 0.0285 |